VRXA (VRXA) Stock Price & Analysis
VRXA (VRXA) fell 9.09% to USD 1.6 as of September 9, 2026 at 09:26 UTC, according to Nexqual real-time market data.
VRXA last closed at USD 1.76; the session ranged USD 1.56–1.9 on volume of 468,262 shares. Market capitalization is $226.25M, with a 52-week range of USD 1.27–27.36 (NGM). Source: Nexqual, September 9, 2026 at 09:26 UTC.
Key Statistics (as of September 9, 2026 at 09:26 UTC)
| Price | USD 1.6 |
|---|---|
| Change | ▼ 9.09% (down) |
| Previous Close | USD 1.76 |
| Open | USD 1.8 |
| Day Range | USD 1.56 – 1.9 |
| 52-Week Range | USD 1.27 – 27.36 |
| Volume | 468,262 shares |
| Market Cap | $226.25M |
| Exchange | NGM |
Technical Analysis (VRXA)
Nexqual's technical model rates VRXA "STRONG SELL" based on 0 bullish and 5 bearish signals across 127 daily candles, as of September 9, 2026 at 09:26 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 44.64 (neutral) |
| vs SMA50 | Below (USD 1.91) |
| MACD | -0.26 (negative) |
Analyst Ratings (VRXA)
Wall Street analysts rate VRXA "None", per Nexqual as of September 9, 2026 at 09:26 UTC.
| Consensus Rating | None |
|---|
Earnings (VRXA)
Source: Nexqual, September 9, 2026 at 09:26 UTC.
Financials & Fundamentals (VRXA)
| Total Revenue | $23,426 |
|---|---|
| Gross Margin | +66.00% |
| Operating Margin | -282662.74% |
| Profit Margin | +0.00% |
| ROE | -871.42% |
| Current Ratio | 0.44 |
| Free Cash Flow | $15.75M |
Source: Nexqual, September 9, 2026 at 09:26 UTC.
Financial Health Score (VRXA)
Nexqual rates VRXA's overall financial health "Mixed" across five dimensions, as of September 9, 2026 at 09:26 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Mixed — No data |
| Cash Flow | Strong — FCF $16M, 67238% margin |
| Efficiency | Critical — ROE -871%, ROA -50.0% |
Ownership (VRXA)
| Insider Ownership | +71.16% |
|---|---|
| Institutional Ownership | +2.02% |
| Shares Outstanding | 141.41M |
| Float | 8.57M |
Source: Nexqual, September 9, 2026 at 09:26 UTC.
Leadership (VRXA)
VRXA is led by Christoph Antz (age 63), Co-Founder, Lead Director & CEO, per Nexqual as of September 9, 2026 at 09:26 UTC.
| Co-Founder, Lead Director & CEO | Christoph Antz (age 63) |
|---|
Major Backers & Investors (VRXA)
Notable institutional backers of VRXA include Picton Mahoney Asset Management, UBS Group AG, according to Nexqual as of September 9, 2026 at 09:26 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Picton Mahoney Asset Management | 0.12% |
| UBS Group AG | 0.11% |
Source: Nexqual, September 9, 2026 at 09:26 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| SUGP | SU Group Holdings Limited | USD 0.65 | ▼ 1.52% |
| MTEN | Mingteng International Corporat | USD 1.05 | ▲ 0.96% |
| PMAX | Powell Max Limited | USD 0.88 | ▲ 2.33% |
| RFAI | RF Acquisition Corp II | USD 41.56 | ▼ 1.14% |
| ELTX | Elicio Therapeutics, Inc. | USD 2.35 | ▼ 6% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 9, 2026 at 09:26 UTC. This page is informational and not investment advice.